Schedule of Investments

Emerald Growth Fund

January 31, 2026 (Unaudited)

 

Shares      Value
(Note 2)
 
COMMON STOCKS: 93.44% 
Consumer Discretionary: 7.35%     
 554,215   Arhaus, Inc.(a)  $5,641,909 
 727,843   Arlo Technologies, Inc.(a)   9,236,328 
 199,537   BJ's Restaurants, Inc.(a)   8,344,637 
 78,417   Boot Barn Holdings, Inc.(a)   13,995,866 
 318,485   IMAX Corp.(a)   11,118,311 
 200,325   Life Time Group Holdings, Inc.(a)   5,843,480 
 577,474   National Vision Holdings, Inc.(a)   15,216,440 
 387,670   OneSpaWorld Holdings, Ltd.   7,617,716 
 594,569   Rush Street Interactive, Inc.(a)   10,506,034 
 34,176   Visteon Corp.   3,105,232 
         90,625,953 
           
Consumer Staples: 3.30%     
 28,000   Five Below, Inc.(a)   5,365,920 
 152,694   Freshpet, Inc.(a)   10,642,772 
 114,419   Ollie's Bargain Outlet Holdings, Inc.(a)   12,621,560 
 423,126   Vital Farms, Inc.(a)   12,037,934 
         40,668,186 
           
Consumer, Cyclical: 0.70%     
 206,522   Black Rock Coffee Bar, Inc.(a)   3,079,243 
 345,294   First Watch Restaurant Group, Inc.(a)   5,521,251 
         8,600,494 
           
Consumer, Non-cyclical: 3.35%     
 453,588   Aveanna Healthcare Holdings, Inc.(a)   3,810,139 
 28,125   Axsome Therapeutics, Inc.(a)   5,182,031 
 55,556   Billiontoone, Inc.(a)   4,583,926 
 99,801   Corvus Pharmaceuticals, Inc.(a)   2,065,881 
 428,847   Invivyd, Inc.(a)   746,194 
 336,137   Lumexa Imaging Holdings, Inc.(a)   4,117,678 
 105,243   Mirum Pharmaceuticals, Inc.(a)   10,863,182 
 104,721   Nektar Therapeutics(a)   3,909,235 
 579,245   Trevi Therapeutics, Inc.(a)   6,064,695 
         41,342,961 
           
Energy: 2.47%     
 246,897   American Superconductor Corp.(a)   7,387,158 
 101,127   Excelerate Energy, Inc.   3,777,094 
 145,986   Solaris Energy Infrastructure, Inc.   8,056,967 
 979,680   TETRA Technologies, Inc.(a)   11,168,352 
         30,389,571 
           
Financial Services: 13.55%     
 159,805   American Integrity Insurance Group, Inc.(a)   2,986,755 
 2,708   Ategrity Specialty Holdings LLC(a)   48,229 
Shares      Value
(Note 2)
 
Financial Services (continued)     
 192,287   Axos Financial, Inc.(a)  $19,034,490 
 179,566   Bancorp, Inc.(a)   10,673,403 
 79,142   Coastal Financial Corp.(a)   7,580,221 
 633,907   Compass, Inc.(a)   7,936,516 
 129,064   Customers Bancorp, Inc.(a)   10,198,637 
 13,531   Enova International, Inc.(a)   2,234,915 
 70,213   GBank Financial Holdings, Inc.(a)   2,284,029 
 353,912   LendingClub Corp.(a)   5,984,652 
 136,911   LendingTree, Inc.(a)   7,757,377 
 150,038   Mid Penn Bancorp, Inc.   4,949,754 
 218,768   Moelis & Co., Class A   15,679,103 
 41,232   Neptune Insurance Holdings, Inc.(a)   1,051,416 
 25,000   Norwood Financial Corp.   760,750 
 94,386   Palomar Holdings, Inc.(a)   11,665,166 
 365,213   Perella Weinberg Partners   8,147,902 
 29,650   Piper Sandler Cos.   10,269,278 
 161,030   Seacoast Banking Corp. of Florida   5,384,843 
 232,362   Skyward Specialty Insurance Group, Inc.(a)   10,367,992 
 284,689   Slide Insurance Holdings, Inc.(a)   4,905,191 
 338,791   Trinity Capital, Inc.   5,701,853 
 89,176   UMB Financial Corp.   11,337,837 
         166,940,309 
           
Healthcare: 13.01%     
 192,168   ACADIA Pharmaceuticals, Inc.(a)   4,829,182 
 633,536   Alphatec Holdings, Inc.(a)   9,395,339 
 142,057   Bridgebio Pharma, Inc.(a)   10,976,744 
 382,344   Cogent Biosciences, Inc.(a)   13,729,973 
 187,077   Collegium Pharmaceutical, Inc.(a)   8,590,576 
 74,747   Corcept Therapeutics, Inc.(a)   2,980,163 
 267,813   Guardant Health, Inc.(a)   30,541,395 
 300,117   KalVista Pharmaceuticals, Inc.(a)   4,684,826 
 180,572   LivaNova PLC(a)   11,865,386 
 10,005   Madrigal Pharmaceuticals, Inc.(a)   4,895,547 
 21,567   Merit Medical Systems, Inc.(a)   1,748,868 
 141,804   RadNet, Inc.(a)   9,940,460 
 798,875   Savara, Inc.(a)   4,313,925 
 106,179   Soleno Therapeutics, Inc.(a)   4,094,262 
 153,485   Spyre Therapeutics, Inc.(a)   4,908,450 
 107,847   TransMedics Group, Inc.(a)   14,448,802 
 406,282   Travere Therapeutics, Inc.(a)   12,631,307 
 447,507   WaVe Life Sciences, Ltd.(a)   5,790,741 
         160,365,946 
           
Industrials: 23.71%     
 153,709   AAR Corp.(a)   16,279,320 
 75,176   AeroVironment, Inc.(a)   20,928,247 
 127,486   Allegiant Travel Co.(a)   11,299,084 
 35,775   Argan, Inc.   12,417,860 
 113,839   ATI, Inc.(a)   13,694,832 
 216,236   Bloom Energy Corp., Class A(a)   32,731,643 
 64,347   Bowman Consulting Group, Ltd.(a)   2,241,206 

   

 

Shares      Value
(Note 2)
 
Industrials (continued)     
 150,655   Byrna Technologies, Inc.(a)  $2,065,480 
 179,041   Cardinal Infrastructure Group, Inc.(a)   4,510,043 
 23,823   Carpenter Technology Corp.   7,571,664 
 151,897   CECO Environmental Corp.(a)   10,242,415 
 1,488,032   Evolv Technologies Holdings, Inc.(a)   9,210,918 
 354,552   First Advantage Corp.(a)   4,786,452 
 305,429   Kratos Defense & Security Solutions, Inc.(a)   31,462,241 
 351,654   Latham Group, Inc.(a)   2,211,904 
 208,114   Mercury Systems, Inc.(a)   19,537,742 
 436,745   Mirion Technologies, Inc.(a)   10,848,746 
 143,133   Modine Manufacturing Co.(a)   26,430,940 
 13,932   Plexus Corp.(a)   2,777,066 
 102,158   Shift4 Payments, Inc.(a)   6,031,408 
 57,383   SPX Technologies Inc(a)   11,959,191 
 29,665   Sterling Infrastructure, Inc.(a)   10,617,400 
 102,180   VSE Corp.   22,333,483 
         292,189,285 
           
Producer Durables: 1.91%     
 130,344   Astronics Corp.(a)   9,873,558 
 60,108   ESCO Technologies, Inc.   13,714,842 
         23,588,400 
           
Technology: 22.64%     
 128,147   Agilysys, Inc.(a)   11,116,752 
 242,324   Applied Optoelectronics, Inc.(a)   10,567,749 
 72,793   Commvault Systems, Inc.(a)   6,238,360 
 175,631   Credo Technology Group Holding, Ltd.(a)   22,003,052 
 222,690   D-Wave Quantum, Inc.(a)   4,725,482 
 242,434   EverQuote, Inc., Class A(a)   5,503,252 
 39,675   Fabrinet(a)   19,418,532 
 79,900   HeartFlow, Inc.(a)   2,386,613 
 60,185   Impinj, Inc.(a)   8,311,548 
 21,435   InterDigital, Inc.   6,997,241 
 172,267   IonQ, Inc.(a)   6,887,235 
 101,429   IPG Photonics Corp.(a)   9,373,054 
 194,073   Kulicke & Soffa Industries, Inc.   11,126,205 
 247,331   nLight, Inc.(a)   11,280,767 
 46,457   Onto Innovation, Inc.(a)   9,386,637 
 350,922   PDF Solutions, Inc.(a)   11,176,866 
 183,378   Q2 Holdings, Inc.(a)   11,231,902 
 241,019   Rambus, Inc.(a)   27,435,193 
 173,131   Semtech Corp.(a)   13,807,197 
 31,790   SiTime Corp.(a)   11,543,267 
 167,424   SkyWater Technology, Inc.(a)   5,300,644 
 126,470   Synaptics, Inc.(a)   10,435,040 
 330,159   TTM Technologies, Inc.(a)   32,421,614 
 344,646   Varonis Systems, Inc.(a)   10,284,237 
         278,958,439 
Shares      Value
(Note 2)
 
Telecommunications: 1.45% 
 45,671   Lumentum Holdings, Inc.(a)  $17,895,725 
           
     Total Common Stocks     
     (Cost $701,820,590)   1,151,565,269 
           
MUTUAL FUND: 5.78%     
Healthcare: 5.78%     
 1,997,035   F/m Emerald Life Sciences Innovation ETF(a)(b)   71,174,327 
           
     Total Mutual Fund     
     (Cost $31,078,469)   71,174,327 
           
           
SHORT TERM INVESTMENTS: 1.15%     
 14,144,446   First American Government Obligations Fund, Class X 3.612% (c)   14,144,446 
           
     Total Short Term Investments     
     (Cost $14,144,446)   14,144,446 
           
           
Total Investments: 100.37%     
(Cost $747,043,505)   1,236,884,042 
           
Liabilities In Excess Of Other Assets: (0.37)%   (4,544,455)
Net Assets: 100.00%  $1,232,339,587 

  

(a)  Non-income producing security.
(b) Affiliated company. See Note 3 in Notes to Quarterly Schedule of Investments.
(c) Represents the 7-day yield.

  

For Fund compliance purposes, the Fund's industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by Fund management. This definition may not apply for purposes of this report, which may combine industry sub-classifications for reporting ease. Industries are shown as a percentage of net assets.

 

See Notes to Quarterly Schedule of Investments. 

   

 

Schedule of Investments

Emerald Finance & Banking Innovation Fund

January 31, 2026 (Unaudited)

 

Shares      Value
(Note 2)
 
COMMON STOCKS: 97.90% 
Communications: 1.12% 
Internet: 1.12% 
 4,053   Shopify, Inc., Class A(a)  $531,875 
           
Consumer, Non-cyclical: 1.65%     
Commercial Services: 1.65%     
 6,520   Affirm Holdings, Inc.(a)   393,156 
 17,146   Klarna Group PLC(a)   395,558 
         788,714 
           
Financial Services: 82.29%     
Banks: 58.73%     
 4,442   Ameris Bancorp   358,114 
 26,010   Axos Financial, Inc.(a)   2,574,730 
 32,889   Bancorp, Inc.(a)   1,954,922 
 10,435   Bank7 Corp.   463,731 
 5,156   CNB Financial Corp.   142,821 
 20,589   Coastal Financial Corp.(a)   1,972,015 
 31,064   Customers Bancorp, Inc.(a)   2,454,677 
 6,314   East West Bancorp, Inc.   722,574 
 22,496   Esquire Financial Holdings, Inc.   2,398,749 
 54,364   Finwise Bancorp(a)   951,914 
 10,289   Five Star Bancorp   407,650 
 4,478   GBank Financial Holdings, Inc.(a)   145,669 
 60,462   Mechanics Bancorp   906,325 
 27,099   Metropolitan Bank Holding Corp.   2,509,367 
 27,293   MVB Financial Corp.   770,754 
 21,124   Northeast Bancorp   2,434,119 
 18,470   Pathward Financial, Inc.   1,667,656 
 3,676   Private Bancorp of America, Inc.(a)   220,560 
 13,110   QCR Holdings, Inc.   1,183,309 
 13,306   Seacoast Banking Corp. of Florida   444,953 
 19,108   Third Coast Bancshares, Inc.(a)   775,021 
 14,347   Western Alliance Bancorp   1,279,035 
 8,733   Wintrust Financial Corp   1,288,030 
         28,026,695 
           
Banks: Diversified: 2.35%     
 7,000   First Busey Corp.   172,550 
 4,373   Mid Penn Bancorp, Inc.   144,265 
 4,256   UMB Financial Corp.   541,108 
 6,277   United Bankshares, Inc.   265,706 
         1,123,629 
           
Computer Services: 0.18%     
 16,576   Opendoor Technologies, Inc.(a)   85,366 
           
Consumer Lending: 7.13%     
 6,371   Enova International, Inc.(a)   1,052,298 
Shares      Value
(Note 2)
 
Consumer Lending (continued)     
 108,783   LendingClub Corp.(a)  $1,839,521 
 22,392   SoFi Technologies, Inc.(a)   510,761 
         3,402,580 
           
Diversified Finan Serv: 2.25%     
 11,558   BitMine Immersion Technologies, Inc.   290,106 
 2,282   Circle Internet Group, Inc.(a)   145,888 
 2,478   Dave, Inc.(a)   405,624 
 2,500   Miami International Holdings, Inc.(a)   104,325 
 5,763   Perella Weinberg Partners   128,572 
         1,074,515 
           
Insurance: 5.35%     
 11,624   American Integrity Insurance Group, Inc.(a)   217,252 
 7,410   Ategrity Specialty Holdings LLC(a)   131,972 
 8,914   Bowhead Specialty Holdings, Inc.(a)   218,928 
 55,248   Neptune Insurance Holdings, Inc.(a)   1,408,824 
 10,211   Skyward Specialty Insurance Group, Inc.(a)   455,615 
 4,900   TWFG, Inc.(a)   122,451 
         2,555,042 
           
Investment Services: 0.51%     
 1,251   Coinbase Global, Inc., Class A(a)   243,620 
           
Mortgage Finance: 2.03%     
 54,049   Rocket Cos., Inc.   969,099 
           
Open End And Misc Investment Vehicles: 1.09%     
 30,950   Trinity Capital, Inc.   520,889 
           
Property And Casualty Insurance: 2.06%     
 533   Kinsale Capital Group, Inc.   211,004 
 3,718   Palomar Holdings, Inc.(a)   459,508 
 39,577   Porch Group, Inc.(a)   312,262 
         982,774 
           
Real Estate: 0.61%     
 23,156   Compass, Inc.(a)   289,913 
           
Industrials: 2.45%     
Transaction Processing Services: 2.45%     
 95,976   Green Dot Corp., Class A(a)   1,168,988 
           
Materials & Processing: 0.78%     
Aluminum: 0.78%     
 28,159   Real Industry, Inc.(a)   372,262 
           
Technology: 9.61%     
Computers: 3.32%     
 27,860   Figure Technology Solutions, Inc.(a)   1,584,677 
           
Internet: 3.23%     
 15,504   Robinhood Markets, Inc.(a)   1,542,338 
   

 

Shares      Value
(Note 2)
 
Software: 3.06% 
 5,000   Bullish(a)  $151,000 
 27,736   Chime Financial, Inc.(a)   705,049 
 31,165   Pagaya Technologies, Ltd.(a)   604,289 
         1,460,338 
           
     Total Common Stocks     
     (Cost $33,408,433)   46,723,314 
           
RIGHTS AND WARRANTS: 0.00%     
 552   Opendoor Technologies, Inc., Strike Price $9.00, Expiration Date 11/20/2026   470 
 552   Opendoor Technologies, Inc., Strike Price $13.00, Expiration Date 11/20/2026   251 
 552   Opendoor Technologies, Inc., Strike Price $17.00, Expiration Date 11/20/2026   219 
 62,749   Paysafe, Ltd., Strike Price $138.00, Expiration Date 12/31/2028   35 
           
     Total Rights and Warrants     
     (Cost $211,219)   975 
           
SHORT TERM INVESTMENTS: 1.94%     
 925,469   First American Government Obligations Fund, Class X 3.612% (b)   925,469 
           
     Total Short Term Investments     
     (Cost $925,469)   925,469 
           
Total Investments: 99.84%     
(Cost $34,545,121)   47,649,758 
           
Other Assets In Excess Of Liabilities: 0.16%   75,551 
Net Assets: 100.00%  $47,725,309 

 

(a)  Non-income producing security.
(b) Represents the 7-day yield.

  

For Fund compliance purposes, the Fund's industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by Fund management. This definition may not apply for purposes of this report, which may combine industry sub-classifications for reporting ease. Industries are shown as a percentage of net assets.

 

See Notes to Quarterly Schedule of Investments.

   

 

Emerald Funds Notes to Quarterly Schedule of Investments

 

January 31, 2026 (Unaudited)

 

1. ORGANIZATION

 

Financial Investors Trust (the “Trust”), a Delaware statutory trust, is an open-end management investment company registered under the Investment

Company Act of 1940, as amended (the “1940 Act”). The Trust consists of multiple separate portfolios or series. This quarterly report describes the Emerald Growth Fund, and Emerald Finance & Banking Innovation Fund (formerly known as "Emerald Banking and Finance Fund") (each a “Fund” and collectively, the “Funds”).

 

The Emerald Growth Fund seeks to achieve long-term growth through capital appreciation. The Emerald Finance & Banking Innovation Fund seeks to achieve long-term growth through capital appreciation with income as a secondary objective.

 

2. SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying Consolidated Schedule of Investments were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of Schedule of Investments in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the Quarterly Schedule of Investments. Actual results could differ from those estimates. The Funds are considered an investment company for financial reporting purposes under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Accounting Standards Codification Topic 946. The following is a summary of significant accounting policies consistently followed by the Funds in preparation of their Schedule of Investments.

 

Investment Valuation: The Funds generally value their securities based on market prices determined at the close of regular trading on the New York Stock Exchange (“NYSE”), normally, 4:00 p.m. Eastern Time, on each business day the NYSE is open for trading.

 

For equity securities and mutual funds that are traded on an exchange, the market price is usually the closing sale or official closing price on that exchange. In the case of equity securities not traded on an exchange, or if such closing prices are not otherwise available, the securities are valued at the mean of the most recent bid and ask prices on such day. Redeemable securities issued by open-end registered investment companies are valued at the investment company’s applicable net asset value, with the exception of exchange-traded open-end investment companies, which are priced as equity securities.

 

The market price for debt obligations is generally the price supplied by an independent third-party pricing service, which may use a matrix, formula or other objective method that takes into consideration quotations from dealers, market transactions in comparable investments, market indices and yield curves. If vendors are unable to supply a price, or if the price supplied is deemed to be unreliable, the market price may be determined using quotations received from one or more brokers–dealers that make a market in the security.

 

Equity securities that are primarily traded on foreign securities exchanges are valued at the preceding closing values of such securities on their respective exchanges, except when an occurrence subsequent to the time a value was so established is likely to have changed such value. In such an event, the fair values of those securities are determined in good faith through consideration of other factors in accordance with procedures established by Emerald Mutual Fund Advisers Trust, (the “Adviser”), as the Funds’ Valuation Designee under the general supervision of the Board of Trustees of the Trust (the “Board” or the “Trustees”).

 

When such prices or quotations are not available, or when the Funds’ Valuation Designee, believes that they are unreliable, securities may be priced using fair value procedures established by the Adviser pursuant to Rule 2a-5 under the 1940 Act and approved by and subject to the oversight of the Board.

 

Fair Value Measurements: Pursuant to Rule 2a-5 under the Investment Company Act of 1940, the Board has appointed the Adviser to serve as the Valuation Designee to perform fair value determinations for investments in the Funds. When such prices or quotations are not available, or when the Valuation Designee believes that they are unreliable, securities may be priced using fair value procedures approved by the Board. The fair valuation policies and procedures have been adopted by the Board for the fair valuation of portfolio assets held by the Funds in the event that (1) market quotations for the current price of a portfolio security or asset are not readily available, or (2) available market quotations that would otherwise be used to value a portfolio security or asset in accordance with the Funds’ Pricing Procedures appear to be unreliable. The Pricing Procedures reflect certain pricing methodologies (or “logics”) that are not “readily available market quotations” and thus are viewed and treated as fair valuations. The Valuation Designee routinely meets to discuss fair valuations of portfolio securities and other instruments held by the Funds.

 

A three-tier hierarchy has been established to classify fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability that are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability that are developed based on the best information available. Various inputs are used in determining the value of each Fund’s investments as of the reporting period end. The designated input levels are not necessarily an indication of the risk or liquidity associated with these investments.

   

 

These inputs are categorized in the following hierarchy under applicable financial accounting standards:

 

  Level 1 – Unadjusted quoted prices in active markets for identical investments, unrestricted assets or liabilities that the Funds have the ability to access at the measurement date;
  Level 2 – Quoted prices which are not active, quoted prices for similar assets or liabilities in active markets or inputs other than quoted prices that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and
  Level 3 – Significant unobservable prices or inputs (including the Funds’ own assumptions in determining the fair value of investments) where there is little or no market activity for the asset or liability at the measurement date.

 

The following is a summary of each input used to value the Funds as of January 31, 2026:

 

Investments in Securities at Value(a)  Level 1 -
Quoted Prices
   Level 2 -
Other Significant
Observable Inputs
   Level 3 -
Significant
Unobservable
Inputs
   Total 
Emerald Growth Fund
Common Stocks  $1,151,565,269   $   $   $1,151,565,269 
Mutual Fund   71,174,327            71,174,327 
Short-Term Investment   14,144,446            14,144,446 
TOTAL  $1,236,884,042   $   $   $1,236,884,042 

 

Investments in Securities at Value(a)  Level 1 -
Quoted Prices
   Level 2 -
Other Significant
Observable Inputs
   Level 3 -
Significant
Unobservable
Inputs
   Total 
Emerald Finance & Banking Innovation Fund
Common Stocks  $46,723,314   $   $   $46,723,314 
Warrants   975            975 
Short-Term Investment   925,469            925,469 
TOTAL  $47,649,758   $   $   $47,649,758 

 

(a)For detailed descriptions of sector and industry, see the accompanying Schedule of Investments.

 

Investment Transactions and Investment Income: Investment transactions are accounted for on the date the investments are purchased or sold (trade date). Realized gains and losses from investment transactions are reported on an identified cost basis, which is the same basis the Funds use for federal income tax purposes. Interest income, which includes accretion of discounts, is accrued and recorded as earned. Dividend income is recognized on the ex-dividend date or for certain foreign securities, as soon as information is available to the Funds. All of the realized and unrealized gains and losses and net investment income, are allocated daily to each class in proportion to its average daily net assets.

 

Real Estate Investment Trusts (“REITs”): The Funds may invest a portion of their assets in REITs and are subject to certain risks associated with direct investment in REITs. REITs may be affected by changes in the value of their underlying properties and by defaults by borrowers or tenants. REITs depend generally on their ability to generate cash flow to make distributions to shareowners, and certain REITs have self-liquidation provisions by which mortgages held may be paid in full and distributions of capital returns may be made at any time. In addition, the performance of a REIT may be affected by its failure to qualify for tax-free pass-through of income under the Internal Revenue Code of 1986, as amended (the “Code”), or its failure to maintain exemption from registration under the 1940 Act. A Fund’s investments in REITs may result in such Fund’s receipt of cash in excess of the REITs’ earnings. If the Fund receives such distributions all or a portion of these distributions will constitute a return of capital to such Fund. Receiving a return of capital distribution from REITs will reduce the amount of income available to be distributed to Fund shareholders. Income from REITs generally will not be eligible for treatment as qualified dividend income. As the final character of the distributions is not known until reported by the REITs on their 1099s, the Funds utilize an average of the prior year’s reallocation information as an estimate for the current year character of distributions.

 

   

 

Emerald Funds Notes to Quarterly Schedule of Investments

 

January 31, 2026 (Unaudited)

 

3. TRANSACTIONS WITH AFFILIATES

 

The following investments are in companies deemed “affiliated” (as defined in Section 2(a)(3) of the 1940 Act) with the Emerald Growth Fund during the period ended January 31, 2026. The Emerald Finance & Banking Innovation Fund had no transactions with affiliates during the period ended January 31, 2026.

 

Security Name  FAIR Value
as of April 30, 2025
   Purchases   Sales   Change in Unrealized
Gain/(Loss)
   Realized Gain/(Loss)   FAIR Value
 as of january 31, 2026
   Share Balance
as OF January 31, 2026
   Dividends 
F/m Emerald Life Sciences Innovation ETF  $45,971,746   $-   $   $25,202,581   $   $71,174,327   $1,997,035   $ 
Total  $45,971,746   $-   $   $25,202,581   $   $71,174,327   $1,997,035   $